STK39 and hypertensive disorder: The small molecule, Compound B, reduces hypertension in animal models by inhibiting WNK phosphorylation of SPAK/OXSR1 (Ishigami-Yuasa et al, 2017), preventing SPAK/OXSR1 activation (Mori et al, 2013).